{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:33Z","timestamp":1753891893558,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Although antinuclear antibody (ANA) is frequently observed in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), its clinical significance in children remains unclear and controversial. In this study, we investigated the prevalence of ANA positivity and the factors associated with it in pediatric MASLD patients without concurrent autoimmune hepatitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed the medical records of patients aged 4\u201318 years diagnosed with MASLD and tested for ANA from January 2015 to December 2020 at 10 hospitals in Korea. All statistical analyses were carried out using SPSS 26.0 and <jats:italic>P<\/jats:italic>-values &amp;lt;0.05 were considered statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of the 439 patients included, ANAs were present in 89 (20.3%); 51 (57.3%) patients had ANA titer &amp;lt;1:80; 22 (24.7%), &amp;lt;1:160; 10 (11.2%), &amp;lt;1:320; and 6 (6.7%), &amp;lt;1:640. Compared to ANA-negative patients, aspartate aminotransferase (AST, <jats:italic>P<\/jats:italic>\u2009=\u20090.003) and alanine aminotransferase (ALT, <jats:italic>P<\/jats:italic>\u2009=\u20090.007) levels were significantly higher in ANA-positive patients. The ALT to Platelet Ratio Index (APRI) score was also associated with the ANA-positive patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.005). To predict ANA positivity using APRI, the area under receiver operating characteristic (AUROC) curve was 0.597 (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), and the APRI cutoff value of &amp;gt;0.893 could predict ANA, with sensitivity and specificity of 42.7% and 72.9%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ANA positivity in pediatric MASLD is associated with greater liver enzyme elevation and increased risk of fibrosis, highlighting the need for careful monitoring in ANA-positive patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1527605","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:19:44Z","timestamp":1740554384000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of antinuclear antibody positivity with liver disease severity in pediatric metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Hyun Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Ho","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Yong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Yoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-2007-979469","article-title":"Interpreting serological tests in diagnosing autoimmune liver diseases","volume":"27","author":"Invernizzi","year":"2007","journal-title":"Semin Liver Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1155\/2010\/431913","article-title":"Autoantibodies and liver disease: uses and abuses","volume":"24","author":"Zeman","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"B6","first-page":"993","article-title":"Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods","volume":"122","author":"Homburger","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104606","DOI":"10.1016\/j.pestbp.2020.104606","article-title":"Pathophysiological impacts of exposure to an endocrine disruptor (tetradifon) on \u03b1-amylase and lipase activities associated metabolic disorders","volume":"167","author":"Badraoui","year":"2020","journal-title":"Pestic Biochem Physiol"},{"key":"B10","first-page":"539","article-title":"Diagnosis of fatty liver disease: is biopsy necessary?","volume":"15","author":"Joy","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"key":"B13","first-page":"74","article-title":"Correlation of smooth-muscle and nuclear antibodies in normal subjects","volume":"27","author":"Andersen","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.2337\/dc08-S055","article-title":"Diagnosis and classification of diabetes mellitus","year":"2008","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/diacare.27.2007.s11","article-title":"Screening for type 2 diabetes","year":"2004","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1542\/peds.2007-2776","article-title":"Blood pressure variability and classification of prehypertension and hypertension in adolescence","volume":"122","author":"Falkner","year":"2008","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"B22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-443-06803-4.00005-8","article-title":"5\u2014laboratory tests in liver disease","volume-title":"Practical Hepatic Pathology: A Diagnostic Approach","author":"Vuppalanchi","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14218\/JCTH.2014.00001","article-title":"Immune components of liver damage associated with connective tissue diseases","volume":"2","author":"Chentoufi","year":"2014","journal-title":"J Clin Transl Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e12696","DOI":"10.1111\/ijpo.12696","article-title":"Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease","volume":"16","author":"Yodoshi","year":"2021","journal-title":"Pediatr Obes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"LWW"},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/MPG.0000000000003534","article-title":"Autoimmune antibodies in children and adolescents with nonalcoholic fatty liver disease","volume":"75","author":"Kohut","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.14309\/ajg.0000000000000676","article-title":"Presence of serum antinuclear antibodies does not impact long-term outcomes in nonalcoholic fatty liver disease","volume":"115","author":"Younes","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.20524\/aog.2019.0406","article-title":"Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography","volume":"32","author":"Papadopoulos","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejim.2024.03.004","article-title":"Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography","volume":"125","author":"Santoro","year":"2024","journal-title":"Eur J Intern Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1527605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:04:37Z","timestamp":1741284277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1527605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":34,"alternative-id":["10.3389\/fped.2025.1527605"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1527605","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"article-number":"1527605"}}